Randomized phase II study of three doses of the integrin inhibitor cilengitide versus docetaxel as second-line treatment for patients with advanced non-small-cell lung cancer
| Image |  |
|---|---|
| Description | scientific article published on 3 July 2012 |
| Author/s |
author: Wolfgang Schuette Penella Woll |
| Publication date | July 3, 2012 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |